Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2005
10/26/2005EP1131312B1 Novel pyrimidine derivatives and processes for the preparation thereof
10/26/2005EP1109559B1 Inhibition of pathogenic processes related to tissue trauma
10/26/2005EP1107762B1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure sexual dysfunction in women
10/26/2005EP1098870B1 Nitrate salt of Cetirizine
10/26/2005EP1087778B1 Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
10/26/2005EP1082107B1 Controlled release lipoic acid
10/26/2005EP1063999B1 Epiallopregnanolone in the treatment of cns disorders
10/26/2005EP1037640B1 Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense
10/26/2005EP1035842B1 IMPROVED HMG CoA REDUCTASE INHIBITOR EXTENDED RELEASE FORMULATION
10/26/2005EP1034793B1 Preventives/remedies for glaucoma
10/26/2005EP1003506B1 Use of eprosartan in the treatment of isolated systolic hypertension
10/26/2005EP0984785B1 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits
10/26/2005EP0973727B1 Activated iododerivatives for the treatment of cancer and aids
10/26/2005EP0950050B1 Method for the crystallisation of a tetrahydopyridin derivative and resulting crystalline forms
10/26/2005EP0910428B1 Photopheresis treatment of chronic hcv infections
10/26/2005EP0896521B1 Composition, barrier film, and method for preventing contact dermatitis
10/26/2005EP0762880B1 Retroviral protease inhibitor combinations
10/26/2005CN1688715A Marker genes for determining renal toxicity
10/26/2005CN1688714A Diagnosis and treatment of the tuberous sclerosis pathway
10/26/2005CN1688707A Tiacumicin production
10/26/2005CN1688603A Treatment and prophylaxis with 4-1BB-binding agents
10/26/2005CN1688589A Beta-lactamase inhibitor prodrug
10/26/2005CN1688586A Broadspectrum substituted oxindole sulfonamide HIV protease inhibitors
10/26/2005CN1688585A Antitumoral analogs of lamellarins
10/26/2005CN1688581A [1, 2, 4]-triazole bicyclic adenosine A2a receptor antagonists
10/26/2005CN1688580A Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors
10/26/2005CN1688578A Phosphodiesterase 4 inhibitors
10/26/2005CN1688576A Thiophene compounds
10/26/2005CN1688572A Piperidinyl targeting compounds that selectively bind integrins
10/26/2005CN1688557A Thiazole compounds for treatment of neurodegenerative disorders
10/26/2005CN1688553A Chemical process
10/26/2005CN1688550A 2, 5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12
10/26/2005CN1688548A Process for preparing quinolin antibiotic intermediates
10/26/2005CN1688547A A-'7-halo-2-quino (xa-) linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents
10/26/2005CN1688545A Phosphodiesterase 4 inhibitors, including n-substituted phenylamine and diphenylamine analogs
10/26/2005CN1688544A Fluoro and sulphonylamino containing 3, 6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists
10/26/2005CN1688540A Novel vinyl carboxylic acid derivatives and their therapeutical use
10/26/2005CN1688535A Novel bioactive diphenyl ethene compounds and their therapeutic applications
10/26/2005CN1688532A Composition based on substituted 1, 3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
10/26/2005CN1688365A Therapeutic use
10/26/2005CN1688364A Use of murine genomic regions identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer
10/26/2005CN1688345A Composition with stabilized redox properties and method of stabilization of redox properties
10/26/2005CN1688341A Medicinal composition for lowering blood lipid level
10/26/2005CN1688337A Use of digoxin immune FAB (ovine) for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients
10/26/2005CN1688331A Nitric oxide and its biomedical significance
10/26/2005CN1688330A Method for cancer therapy using herbal extracts
10/26/2005CN1688325A Black soybean polysaccharides
10/26/2005CN1688322A Antiseptic solutions containing silver chelated with polypectate and EDTA
10/26/2005CN1688321A Composition for treating hemorrhoids
10/26/2005CN1688320A Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
10/26/2005CN1688319A Use of corrinoids in the treatment of skin diseases
10/26/2005CN1688318A Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy
10/26/2005CN1688317A Transparent eye drops containing latanoprost
10/26/2005CN1688316A Prophylaxis and treatment of infectious diseases
10/26/2005CN1688315A Use of selective COX-2 inhibitors for the treatment of urinary incontinence
10/26/2005CN1688314A Medicinal composition containing an HMG-CoA reductase inhibitor
10/26/2005CN1688313A Orally dispersible pharmaceutical piribedil composition
10/26/2005CN1688312A Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
10/26/2005CN1688311A Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
10/26/2005CN1688310A Novel crystalline forms of gatifloxacin
10/26/2005CN1688309A Use of 5-HT2 receptor antagonists for the treatment of sleep disorders
10/26/2005CN1688308A Inhalation medicaments containing a novel anticholinesterase drug in conjunction with corticosteroids and betamimetic drugs
10/26/2005CN1688307A 4-aminopiperidine derivatives, processes for their preparation and their use as medicaments
10/26/2005CN1688306A Use of posaconazole for the treatment of fungal infections
10/26/2005CN1688305A Novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure
10/26/2005CN1688304A Formulations comprising a basic indolinone compound
10/26/2005CN1688303A Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies
10/26/2005CN1688302A Use of hydroxyoleic acid and similar compounds in the production of medicaments
10/26/2005CN1688301A Dosage forms and related therapies
10/26/2005CN1688300A Peritoneal dialysate containing taurine
10/26/2005CN1688299A Suppression of cytotoxic protein conformers
10/26/2005CN1688298A Composition, synthesis and therapeutic applications of polyamines
10/26/2005CN1688297A Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate
10/26/2005CN1688296A Injectable 2, 6-diisopropylphenol-containing anesthetic composition and methods
10/26/2005CN1688295A Multilayer dosage forms, which contain active substances and which comprise a neutral core, and an inner and outer coating consisting of methacrylate copolymers and methacrylate monomers
10/26/2005CN1688294A Enteric composition for the manufacture of soft capsule wall
10/26/2005CN1688291A Immediate release dosage forms containing solid drug dispersions
10/26/2005CN1688285A Repair of DNA mutagenic damage
10/26/2005CN1688279A Oral composition providing enhanced oral hygiene properties
10/26/2005CN1688270A Topical patch and reagent kit containing a delayed-type hypersensitivity inducer
10/26/2005CN1688194A 2, 4, 5-trisubstituted imidazoles and their use as anti-microbial agents
10/26/2005CN1688193A Mixed compositions for controlling parasitic insects
10/26/2005CN1686549A Medicinal composition for treating high blood pressure
10/26/2005CN1686547A Long time use compound preparation for treating diabetes
10/26/2005CN1686159A New use of achyranthes polysaccharide sulphate for anti Aids and immune regulation
10/26/2005CN1686158A Adhesive bandage containing hyaluronic acid biological composition
10/26/2005CN1686157A Rhodiola polyose injection agent and its preparation method
10/26/2005CN1686156A Clamycin structurization emulsion composition
10/26/2005CN1686155A Astragalus glycoside fatty emulsion and its preparation technology
10/26/2005CN1686154A Heart brain shutong dispersion tablet and its preparation method
10/26/2005CN1686153A Medicinal preparation for treating cerebral thrombosis, coronary heart disease and stenocardia
10/26/2005CN1686152A Traditional Chinese medicinal preparation for treating chronic bronchitis, its preparation method and application
10/26/2005CN1686151A Enteric dissolving preparation of compound glycyrrbizic acid and its salt and its preparation method
10/26/2005CN1686150A Notoginseng total saponin slow release preparation
10/26/2005CN1686149A New type medicinal film for treating oral cavity and brotic wound surface and its preparation method
10/26/2005CN1686148A Use of liposoluble stilbene glycoside kind compound in treating ischemic heart brain blood vessel disease and its preparation
10/26/2005CN1686147A Hongjingtian glycoside freeze dried powder injection agent and its preparation method
10/26/2005CN1686146A Adefovirdipivoxil aster and polyvinyl pyrrolidone glass state solid solution and its preparation method
10/26/2005CN1686145A Doxycycline oral cavity adhesion tablet
10/26/2005CN1686144A Slow release micropill, capsule containing Chinese medicine cyclo virobuxine D and its preparation method
1 ... 4492 4493 4494 4495 4496 4497 4498 4499 4500 4501 4502 4503 4504 4505 4506 4507 4508 4509 4510 4511 4512 ... 7860